Does Nutritional Risk Screening 2002 correlate with  dyspnea status of patients with GOLD stage 3-4 chronic obstructive pulmonary disease: a Cohort study.

N. Ogan (Ankara, Turkey), F. Bodur Yildirim (Ankara, Turkey), B. Süzen (Ankara, Turkey), A. Baha (Ankara, Turkey), E. Akpinar (Ankara, Turkey)

Source: International Congress 2018 – Nutrition and metabolic syndrome in COPD
Session: Nutrition and metabolic syndrome in COPD
Session type: Thematic Poster
Number: 711
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
N. Ogan (Ankara, Turkey), F. Bodur Yildirim (Ankara, Turkey), B. Süzen (Ankara, Turkey), A. Baha (Ankara, Turkey), E. Akpinar (Ankara, Turkey). Does Nutritional Risk Screening 2002 correlate with  dyspnea status of patients with GOLD stage 3-4 chronic obstructive pulmonary disease: a Cohort study.. 711

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Late Breaking Abstract - Disease trajectories in GOLD B chronic obstructive pulmonary disease (COPD) patients  – nationwide data from Denmark
Source: Virtual Congress 2021 – COVID - 19, smoking and e-cigarettes
Year: 2021


Anemia in COPD patients of Korean obstructive lung disease (KOLD) cohort
Source: International Congress 2015 – Multidimensional analysis of respiratory problems
Year: 2015

Chronic obstructive pulmonary disease and comorbidities
Source: International Congress 2015 – Risk factors and co-morbidities in asthma and COPD
Year: 2015

Do GOLD stages of COPD severity really correspond to differences in health status?
Source: Eur Respir J 2003; 22: 444-449
Year: 2003



Distribution and significance of GOLD 2011 disease severity classification in patients with COPD in China: A national cross-sectional survey
Source: Annual Congress 2013 –COPD: acute exacerbations and others
Year: 2013

Assessment of patients preferences regarding characteristics associated with treatment of chronic obstructive pulmonary disease
Source: International Congress 2014 – Systemic biomarkers for airway diseases
Year: 2014

The Study to Understand Mortality and Morbidity in COPD (SUMMIT) study protocol
Source: Eur Respir J 2013; 41: 1017-1022
Year: 2013



Impact of chronic obstructive pulmonary disease (COPD) and patients' absence from work in Greece - the GOLDEN II study
Source: International Congress 2014 – Diagnosis and treatment of COPD in primary care
Year: 2014

Burden of obstructive lung disease study in Tehran: Prevalence and risk factors of COPD
Source: International Congress 2015 – Management of COPD and other respiratory diseases in primary care
Year: 2015

Clinical presentation of chronic obstructive pulmonary disease (COPD): Study on-sint
Source: International Congress 2014 – Clinical assessment of airway diseases
Year: 2014


Cardiovascular status of patients with a severe form of COPD
Source: International Congress 2015 – Diagnosing and management of COPD in primary care
Year: 2015


Disease progression and changes in risk groups' classification over a period of one year in the GPs based Swiss chronic obstructive pulmonary disease (COPD) cohort
Source: International Congress 2014 – Diagnosis and treatment of COPD in primary care
Year: 2014


Frequency of depression in patients with chronic obstructive pulmonary disease
Source: International Congress 2014 – The assessment of comorbidities
Year: 2014

Prevalence of co-morbidities with chronic obstructive pulmonary disease (COPD) in a primary care cohort
Source: International Congress 2014 – Clinical presentations
Year: 2014


Chronic obstructive pulmonary disease assessment test (CAT) in patients with COPD, chronic heart failure (CHF), and both
Source: International Congress 2016 – Features and impact of comorbidities in COPD
Year: 2016

Socioeconomic status shaping GOLD A-D classification in patients with chronic obstructive pulmonary disease
Source: International Congress 2016 – COPD diagnosis and management
Year: 2016

Clinical and epidemiological characteristics of chronic obstructive pulmonary disease (COPD) patients in Spain (VICE Study)
Source: Eur Respir J 2006; 28: Suppl. 50, 35s
Year: 2006

Lung cancer in patient with chronic obstructive pulmonary disease (comorbidity by smokers-a cumulative effect of exogenic and endogenic factors? Part II)
Source: Annual Congress 2013 –COPD treatment
Year: 2013

Do co-morbidities in patients with chronic obstructive pulmonary disease affect outcomes?
Source: International Congress 2014 – The assessment of comorbidities
Year: 2014


Comparison of gender-related risk factors for COPD – Results from the Canadian obstructive lung disease (CanCOLD) study
Source: Annual Congress 2013 –Factors associated with outcomes in COPD
Year: 2013